USPTO serial 99879169
GRACKLE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIBBLE,JENNA M
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with GRACKLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Brooklyn, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shanti W Hubbard
Shanti W Hubbard Chan Hubbard PLLC14 Lawton StreetSuite 4484Brooklyn, NY 11221Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | provision of downloadable electronic datasets and files and reports in the field of medical diagnostics and immunology; provision of downloadable software in the field of medical diagnostics; provision of diagnostic instruments; Downloadable software for use in the diagnosis of disease conditions; downloadable software using artificial intelligence for processing and generation of reports for medical purposes; downloadable software for processing and generation of reports for medical purposes; downloadable software for processing and generation of insights for clinical trials; downloadable software for processing and generation of insights for drug discovery, design, development, and research | ACTIVE | — |
| 042 | software, software development, and scientific services in the field of medical diagnostics and immunology; provision of non-downloadable software for medical diagnostics purposes; provision of non-downloadable software for research and development in the pharmaceutical and medical fields; provision of a software platform utilizing artificial intelligence for medical diagnostics; development and design of medical diagnostic apparatus; medical and research services, namely development of medical diagnostic tools; laboratory research in the field of medical diagnostics; scientific research and technological services in the field of medical diagnostics; Creating and designing and improving of datasets, namely, computational computer modeling using and analyzing immunology data for training artificial intelligence (AI) models and large language models (LLM) to learn patterns and make predictions and visualize data models; pharmaceutical drug development; pharmaceutical target identification and development; disease mechanism identification and discovery; research and development services in the fields of epidemiology, immunology, and prognostics; research and development services for target, drug, and biologic discovery, development, and derisking; medical and scientific research and development; development of artificial intelligence clinicians; development of clinical co-pilots featuring artificial intelligence; clinical trial services; science and technology services; medical and scientific research services; artificial intelligence as a service (AIAAS) services | ACTIVE | — |
| 044 | Consulting services in the fields of medical diagnostics; Medical diagnostic testing, monitoring, and reporting services; medical diagnostic services; Medical and testing information services, namely, providing information regarding diagnostic testing results, testing procedures, disease conditions and disease prevention; medical research services in the field of immunology, epidemiology, and prognostics; consulting services in the fields of pharmaceuticals, biotech, and immunology; personalized medicine services; medical decision-making services; provision of medical and clinical services incorporating artificial intelligence; medical services in the fields of epidemiology, immunology, and prognostics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 11, 2026 | NWAP | NEW APPLICATION ENTERED | — |